On a weekly basis, the Genetics Policy Hub (GPH), compiles all posts found on the GPH X (formerly Twitter), @geneticspolicy, in the GPH Weekly Wrap-Up to provide information about proposed and enacted US state and Federal legislation and regulation. Enter your email below to subscribe and receive the Weekly Wrap-Up in your inbox, and find more information about genetics policy across the US at geneticspolicy.nccrcg.org!
The April 8-12th 2024 GPH X (formerly Twitter) Wrap-Up of the Week includes:
Enacted State Legislation
2 bills enacted in Virginia relating to sickle cell disease.
Introduced State Legislation
A bill introduced in New Jersey relating to coverage for biomarker testing.
State Legislation
Enacted
Virginia
On April 4, 2024, #VA Governor @GlennYoungkin signed a bill to provide for an annual review of medications, services, and forms of treatment available to individuals diagnosed with #SickleCell disease and eligible for coverage under #Medicaid. Learn more: https://bit.ly/3vLqrm4
#VA Governor @GlennYoungkin signed a bill on April 4, 2024, to create a statewide registry of #SickleCell disease patients to be maintained by the VA State Health Commissioner. Learn more at: https://bit.ly/3vNnLUS
Introduced
New Jersey
On April 8, 2024, the #NJ Assembly introduced a bill to require health insurers to provide coverage for #BiomarkerTesting. Learn more at: https://bit.ly/4cQqU77
Enter your email below to subscribe and receive the Weekly Wrap-Up in your inbox, and find more information about genetics policy across the US at geneticspolicy.nccrcg.org!